Codes / ICD10CM / C96.5

C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Multifocal and unisystemic Langerhans-cell histiocytosis
  • Also known as Langerhans Cell Histiocytosis (LCH), Unisystemic LCH.

Summary

Langerhans-cell histiocytosis is a rare disorder characterized by an abnormal proliferation of Langerhans cells, a type of dendritic cell that normally helps regulate the immune system. In this condition, these cells increase uncontrollably, leading to tissue damage and inflammation. The multifocal and unisystemic form involves multiple lesions or sites within a single organ system, distinguishing it from multisystemic disease.

Causes

The exact cause of Langerhans Cell Histiocytosis is not fully understood, but it is believed to be related to genetic mutations in somatic cells. Some suggest it may have a neoplastic cause due to clonal proliferation, though the underlying triggers remain unclear.

Risk Factors

  • While LCH can occur at any age, it is most common in children between the ages of 1 and 3. Having a family member with the condition may increase risk, though LCH is not usually considered hereditary.

Symptoms

Symptoms can vary widely depending on the organ system affected. They may include skin rashes, bone pain, swollen lymph nodes, respiratory issues, and in severe cases, organ dysfunction or failure.

Diagnosis

Diagnosis is made through a combination of clinical evaluation, imaging studies (such as X-rays and CT scans), and histopathological examination of tissue biopsies. A definitive diagnosis often involves identifying characteristic Langerhans cells and ruling out other conditions.

Treatment Options

Treatment depends on the extent and location of the disease. Options may include observation for mild cases, localized therapies (e.g., surgery or radiation), or systemic treatments (e.g., chemotherapy) for more extensive disease.

Prognosis and Follow-Up

Prognosis varies based on the severity and organ involvement. Regular follow-up is essential to monitor for recurrence or progression, especially in cases involving critical organs.

Complications

Potential complications include organ damage, functional impairment, and, in rare cases, progression to multisystemic disease.

Lifestyle & Prevention

No specific preventive measures are known, as the cause is not fully understood. Maintaining overall health and prompt medical attention for symptoms may help manage the condition.

When to Seek Professional Help

Seek medical care if you experience persistent symptoms such as unexplained rashes, bone pain, or organ-related issues, especially if they worsen over time.

Tips for Medical Coders

When coding for C96.5, ensure documentation specifies "multifocal and unisystemic" involvement to distinguish it from other LCH forms. Verify that the affected organ system is clearly documented, as this impacts code assignment.

Medical Policies and Guidelines

Related policies from health plans

Zoledronic Acid Agents
Book a walkthrough

C96.5 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.